Preventing Severe COVID-19 with Tixagevimab-Cilgavimab in Hematological Patients Treated with Anti-CD20 Monoclonal Antibodies: An International Multicenter Study
在接受抗CD20单克隆抗体治疗的血液病患者中，使用Tixagevimab-Cilgavimab预防重症COVID-19：一项国际多中心研究
期刊:Infectious Diseases and Therapy
影响因子:5.3
doi:10.1007/s40121-024-01089-9
Azuly, Hovav; Shafat, Tali; Grupel, Daniel; Porges, Tzvika; Abuhasira, Ran; Belkin, Ana; Deri, Ofir; Oster, Yonatan; Zahran, Shadi; Horwitz, Ehud; Horowitz, Netanel A; Khatib, Hazim; Batista, Marjorie Vieira; Cortez, Anita Cassoli; Brosh-Nissimov, Tal; Segman, Yafit; Ishay, Linor; Cohen, Regev; Atamna, Alaa; Spallone, Amy; Chemaly, Roy F; Ramos, Juan Carlos; Chowers, Michal; Rogozin, Evgeny; Oren, Noga Carmi; Keske, Şiran; Barchad, Orit Wolfovitz; Nesher, Lior
